Miromatrix CEO Jeff Ross, PhD Participates in Alliance for Regenerative Medicine

Miromatrix CEO Jeff Ross, PhD, is now serving as co-chair of the Tissue Engineering and Biomaterials Committee of the Alliance for Regenerative Medicine (ARM). This committee works to accelerate development and commercialization by identifying the regulatory, reimbursement and policy requirements facing companies and institutions developing tissue engineered and biomaterial-based regenerative medicine products. In conjunction with this role, Ross presented ARM's perspective on the field of regenerative medicine at the 2018 TERMIS World Congress in Kyoto, Japan this week.

Regenerative Medicine.jpg